Section 95.1215, Medical Device Radiocommunication Services (MedRadio) - Disclosure Policies and Section 95.1217, Labeling Requirements

ICR 201202-3060-004

OMB: 3060-0936

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2012-05-09
ICR Details
3060-0936 201202-3060-004
Historical Active 200904-3060-017
FCC WTB/Mobility
Section 95.1215, Medical Device Radiocommunication Services (MedRadio) - Disclosure Policies and Section 95.1217, Labeling Requirements
Revision of a currently approved collection   No
Regular
Approved without change 06/19/2012
Retrieve Notice of Action (NOA) 05/09/2012
  Inventory as of this Action Requested Previously Approved
06/30/2015 36 Months From Approved 06/30/2012
100 0 20
100 0 20
0 0 0

The information collection requires manufacturers of transmitters for the Medical Implant Communications Service (MICS) to include with each transmitting device a statement regarding harmful interference and to label the device in a conspicuous location on the device. The requirements will allow use of potential life-saving medical technology without causing interference to other users of the 402-405 MHz band.

US Code: 47 USC 303 Name of Law: Communications Act of 1934, as amended
   US Code: 47 USC 154 Name of Law: Communications Act of 1934, as amended
  
None

3060-AJ25 Final or interim final rulemaking 77 FR 4252 01/27/2012

  77 FR 12302 02/29/2012
77 FR 27059 05/08/2012
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 100 20 0 0 80 0
Annual Time Burden (Hours) 100 20 0 0 80 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
The 80 hour increase in burden is due to an increase in the number of manufacturers. The Commission adopted a Report and Order, FCC 11-176, which amended Parts 2 and 95 of the Commission's rules to provide additional spectrum for the Medical Device Radiocommunication Service which requires manufacturers of MedRadio programmer/control transmitters to include a statement on the device in a conspicious location, or if it is not feasible to place the statement on the device, in the instruction manual.

$0
No
No
No
No
No
Uncollected
Jeff Tobias 202 418-0680 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
05/09/2012


© 2024 OMB.report | Privacy Policy